A nationwide experience of biological treatments in children with eosinophilic esophagitis

Pending marketing authorization, biological therapies for pediatric eosinophilic esophagitis are mainly prescribed after failure of first-line treatments and on a compassionate basis in France. Dupilumab is the biotherapy most frequently used, is associated with clinical and histological efficacy and is well-tolerated. Children and adolescents requiring biologics appear to be younger and more severe at diagnosis than naive pediatric patients in Europeans registries.

Authors

Institutions

Publication Details

Journal
Pediatric Research
Published
2025-06-07
DOI
https://doi.org/10.1038/s41390-025-04011-2
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A nationwide experience of biological treatments in children with eosinophilic esophagitis

C. Hoarau, Léa Chantal Tran, Madeleine Aumar, Raphaël Enaud et al.
Pediatric Research
Eosinophilic Esophagitis
article

A nationwide experience of biological treatments in children with eosinophilic esophagitis

C. Hoarau, Léa Chantal Tran, Madeleine Aumar, Raphaël Enaud, Stéphanie Lejeune, L. Bridoux‐Henno, Mathilde Butori, Alexandre Fabre, Frédèric Gottrand, A. Lemoine, Marjorie Bonneton, Georges Dimitrov, Nicolas Caron, Nicolas Kalach, Julie Rebeuh, Hélène Lengline, Claire Dupont, J Soudant, Émeline Caillau
article en

Abstract

Pending marketing authorization, biological therapies for pediatric eosinophilic esophagitis are mainly prescribed after failure of first-line treatments and on a compassionate basis in France. Dupilumab is the biotherapy most frequently used, is associated with clinical and histological efficacy and is well-tolerated. Children and adolescents requiring biologics appear to be younger and more severe at diagnosis than naive pediatric patients in Europeans registries.

Pediatric Research
Inserm (FR), Université Catholique de Lille (FR), Aix-Marseille Université (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Hôpital Femme Mère Enfant (FR), Hôpital Armand-Trousseau (FR), Assistance Publique Hôpitaux de Marseille (FR), Centre Hospitalier Universitaire de Tours (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Hôpital Jeanne de Flandre (FR), Bordeaux Population Health (FR), Délégation Centre-Est (FR), Hôpital Robert-Debré (FR), Lille Inflammation Research International Center (FR), Fondation Lenval (FR), Groupe Hospitalier de l'Institut Catholique de Lille (FR), Centre hospitalier universitaire d'Orléans (FR), Centre Hospitalier Universitaire de Rennes (FR), Institute for Translational Research in Inflammation (FR), Université de Rennes (FR), Université de Strasbourg (FR), Université de Caen Normandie (FR)
Centre hospitalier régional universitaire de Lille
Openalex Percentile: Top 77%
Eosinophilic Esophagitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.